Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Kcnk2em1/Cya
Common Name:
Kcnk2-KO
Product ID:
S-KO-02762
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Kcnk2-KO
Strain ID
KOCMP-16526-Kcnk2-B6J-VB
Gene Name
Kcnk2
Product ID
S-KO-02762
Gene Alias
A430027H14Rik; TREK-1
Background
C57BL/6JCya
NCBI ID
16526
Modification
Conventional knockout
Chromosome
1
Phenotype
MGI:109366
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Kcnk2em1/Cya mice (Catalog S-KO-02762) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000193319
NCBI RefSeq
NM_001159850.1
Target Region
Exon 3
Size of Effective Region
~1.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Kcnk2, also known as TREK1, is a member of the two-pore domain potassium (K2P) channel family. It is crucial for maintaining the resting membrane potential of cells, which is essential for normal cellular function. By controlling the potassium ion flow, it influences the excitability of neurons and other excitable cells. Kcnk2 has been associated with multiple biological pathways, and its function is vital in the central nervous system (CNS) [2,3,6]. Zebrafish, with their two orthologs kcnk2a and kcnk2b, serve as a useful in vivo research model to study Kcnk2-targeted strategies due to the similar biophysiological and pharmacological properties to human KCNK2 [7].

In esophageal squamous cell carcinoma (ESCC), miR-132-3p can bind to the 3'-untranslated region of Kcnk2 and inhibit its gene expression. Knockdown of Kcnk2 promotes ESCC progression in vitro, suggesting that Kcnk2 may act as a suppressor in ESCC [1]. In spinal cord ischemia-reperfusion injury, overexpression of Kcnk2 enhanced the viability and inhibited the apoptosis of hypoxia/reoxygenation-treated PC12 cells. The transcription factor Foxd3 activates miR-214, which targets Kcnk2, indicating a regulatory mechanism in this injury [4]. In pulmonary arterial hypertension, the up-regulated expression of Kcnk2 in pulmonary arterial smooth muscle cells (PASMCs) facilitates their proliferation and migration via enhanced Ca2+ signaling and JNK signaling pathway [5]. In the context of the blood-brain barrier (BBB), TREK1 (Kcnk2) was downregulated upon inflammation. Blocking of TREK1 increased lymphocyte migration, while activation had the opposite effect. In TREK1-deficient (Trek1 (-/-)) mice, brain endothelial cells displayed an inflammatory phenotype and leukocyte trafficking was facilitated, as demonstrated in experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis [2].

In conclusion, Kcnk2 plays essential roles in maintaining cell membrane resting potential and influencing cell excitability. Model-based research, especially KO mouse models like in the study of BBB-related diseases, has revealed its significance in various disease conditions such as ESCC, spinal cord injury, and pulmonary arterial hypertension. Understanding Kcnk2's functions provides insights into the underlying mechanisms of these diseases, potentially guiding the development of new therapeutic strategies.

References:

1. Wang, Jing, Li, Jiaqiong, Cheng, Dan, Li, Xiang, Dong, Zigang. 2023. miR-132-3p promotes heat stimulation-induced esophageal squamous cell carcinoma tumorigenesis by targeting KCNK2. In Molecular carcinogenesis, 62, 583-597. doi:10.1002/mc.23504. https://pubmed.ncbi.nlm.nih.gov/37014157/

2. Bittner, Stefan, Ruck, Tobias, Fernández-Orth, Juncal, Meuth, Sven G. 2014. TREK-king the blood-brain-barrier. In Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 9, 293-301. doi:10.1007/s11481-014-9530-8. https://pubmed.ncbi.nlm.nih.gov/24557892/

3. Bockenhauer, D, Zilberberg, N, Goldstein, S A. . KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. In Nature neuroscience, 4, 486-91. doi:. https://pubmed.ncbi.nlm.nih.gov/11319556/

4. Li, Ran, Zhao, Kunchi, Ruan, Qing, Meng, Chunyang, Yin, Fei. 2020. The transcription factor Foxd3 induces spinal cord ischemia-reperfusion injury by potentiating microRNA-214-dependent inhibition of Kcnk2. In Experimental & molecular medicine, 52, 118-129. doi:10.1038/s12276-019-0370-8. https://pubmed.ncbi.nlm.nih.gov/31959866/

5. Shima, Natsumi, Yamamura, Aya, Fujiwara, Moe, Suzuki, Yoshiaki, Yamamura, Hisao. 2024. Up-regulated expression of two-pore domain K+ channels, KCNK1 and KCNK2, is involved in the proliferation and migration of pulmonary arterial smooth muscle cells in pulmonary arterial hypertension. In Frontiers in cardiovascular medicine, 11, 1343804. doi:10.3389/fcvm.2024.1343804. https://pubmed.ncbi.nlm.nih.gov/38410243/

6. Le Guen, Yann, Philippe, Cathy, Riviere, Denis, Mangin, Jean-François, Frouin, Vincent. 2018. eQTL of KCNK2 regionally influences the brain sulcal widening: evidence from 15,597 UK Biobank participants with neuroimaging data. In Brain structure & function, 224, 847-857. doi:10.1007/s00429-018-1808-9. https://pubmed.ncbi.nlm.nih.gov/30519892/

7. Nasr, Nathalie, Faucherre, Adèle, Borsotto, Marc, Jopling, Chris, Moha Ou Maati, Hamid. 2018. Identification and characterization of two zebrafish Twik related potassium channels, Kcnk2a and Kcnk2b. In Scientific reports, 8, 15311. doi:10.1038/s41598-018-33664-9. https://pubmed.ncbi.nlm.nih.gov/30333618/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest